CRA International, Inc. (CRAI) Market Cap & Valuation Ratios
CRA International, Inc. (CRAI) has a market cap of $1.3B, a trailing P/E of 26.6 and a price-to-sales ratio of 1.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
CRAICRA International, Inc.Follow CRAI — free
—
Price chart with a free account
- Market cap
- 1.3B
- P/E TTM
- 26.6
- Dividend yield
- 1.1%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
consulting services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CRAI | 1.3 | 26.6 | 1.8 | 15.6 | -2.2% | +11% | 10% | 14% |
| BAH | 9.3 | 12.2 | 1.2 | 11.2 | 10.6% | -6% | 9% | 20% |
| NIQ | 5.9 | — | 2.1 | 12.5 | 8.6% | +9% | 2% | 2% |
| FCN | 4.3 | 18.9 | 1.3 | 12.1 | 8.3% | +7% | 10% | 12% |
| HURN | 3.1 | 29.3 | 2.2 | 17.4 | 4.5% | +14% | 10% | 12% |
| ICFI | 1.7 | 19.5 | 1.2 | 10.6 | 11.7% | -8% | 8% | 8% |
| ROMA | 0.4 | — | — | — | — | -22% | -315% | -44% |
| III | 0.3 | 25.8 | 1.3 | 13.4 | 5.7% | +4% | 8% | 10% |
| PPHC | 0.3 | — | 1.5 | — | 5.2% | +25% | -18% | -30% |
| FORR | 0.2 | — | 0.6 | — | 1.3% | -8% | -13% | -43% |
| RGP | 0.1 | — | 0.1 | — | -11.3% | -20% | -10% | -38% |
| Median of these 10 | 19.5 | 1.3 | 12.3 | 5.7% | -1% | 5% | 5% |
P/E 26.6 vs. a peer median of 19.5; EV/Sales 1.8 vs. 1.3. CRAI's own P/E sits at the 79th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesNIQ and ROMA and PPHC and FORR and RGP have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
CRA International, Inc. — questions
- What is CRA International, Inc.'s market cap?
- $1.3B.
- What is CRA International, Inc.'s P/E ratio?
- 26.6 on trailing twelve-month earnings to 2026-07-04.
- What is CRA International, Inc.'s price-to-sales ratio?
- 1.6.
Every figure on this page comes from CRA International, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.